International Journal of Clinical Research
International Journal of Clinical Research. 2024; 8: (12) ; 10.12208/j.ijcr.20240526 .
总浏览量: 121
银川国龙骨科医院 宁夏银川
*通讯作者: 张淑菊,单位:银川国龙骨科医院 宁夏银川;
目的 评估冠脉介入在老年慢性冠脉综合症患者中使用的效果以及对临床中的影响。方法 收集2022年8月-2024年8月阶段中到院经冠脉造影证实可进行介入治疗慢性冠脉综合症老年患者作为此次研究的案例,人数共80例,按照患者治疗意愿分成介入组与观察组,每组各40例,观察组常规药物治疗,观察病情发展,介入组接受冠脉介入治疗,比较两组治疗效果。结果 介入组治疗后,心功能指标恢复佳,组间对比,P<0.05;介入组心绞痛分级占比与观察组有明显差异,P<0.05;介入组并发症少,心绞痛相关指标优,与观察组有明显差异,P<0.05。结论 老年慢性冠脉综合症患者中通过冠脉介入手术治疗能够提高患者心功能,减少并发症,降低患者心绞痛等级,值得推广使用。
Objective To evaluate the effect of coronary intervention in elderly patients with chronic coronary syndrome and its impact on clinical practice.
Methods A total of 80 elderly patients with chronic coronary syndrome who were admitted to the hospital and confirmed by coronary angiography to be eligible for interventional treatment from August 2022 to August 2024 were collected as cases for this study. According to the patients' treatment willingness, they were divided into an intervention group and an observation group, with 40 cases in each group. The observation group received conventional drug treatment and observed the development of the disease, while the intervention group received coronary intervention treatment. The treatment effects of the two groups were compared.
Results After treatment in the intervention group, cardiac function indicators recovered well, and the inter-group comparison was P<0.05; the proportion of angina pectoris grades in the intervention group was significantly different from that in the observation group, P<0.05; the intervention group had fewer complications and better angina-related indicators, which were significantly different from those in the observation group, P<0.05.
Conclusion Coronary artery intervention in elderly patients with chronic coronary syndrome can improve cardiac function, reduce complications, and lower the grade of angina pectoris, which is worth promoting.
[1] 石云霄,王卫国,程常福,李佳.冠脉介入后心绞痛患者心力衰竭的Nomogram风险模型构建及重要性矩阵分析[J].海南医学,2024,35(16):2288-2294.
[2] 徐远鹏,翟晓晓,姬春好.地奥心血康辅助阿托伐他汀联合氯吡格雷治疗高血压合并冠脉介入术后心绞痛的效果[J].中国药物滥用防治杂志,2024,30(07):1313-1316+1320.
[3] 孟繁盛,张彤.冠脉介入治疗联合抗阻训练对冠心病心绞痛患者心肺功能及运动耐力的影响[J].中国医学创新, 2024, 21(17):136-140.
[4] 吴雷,耿国英,姬劲锐.血清miR-122表达水平与冠心病心绞痛患者PCI后非靶血管斑块进展的关系[J].中国老年学杂志,2024,44(02):259-263.
[5] 李劲松,田茂,刘晓楚,王斌,汪宇.复方丹参滴丸联合氯吡格雷片对老年冠心病冠脉内介入术后心绞痛患者的治疗效果[J].川北医学院学报,2023,38(12):1603-1607.
[6] Spertus JA, Jones PG, Maron DJ, et al. Healthstatus outcomes with invasive or conservative care in coronary disease[J]. N Engl J Med, 2020, 382(15):14081419.
[7] Xaplanteris P, Fournier S, Pijls N, et al. Fiveyear outcomes with PCI Ggided by fractional flow reserve[J]. N Engl J Med, 2018, 379(3): 250259.
[8] Navarese EP, Lansky AJ, Kereiakes DJ, et al. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and metaanalysis[J]. Eur Heart J, 2021, 42(45): 46384651.
[9] Laukkanen JA, Kunutsor SK. Revascularization versus medical therapy for the treatment of stable coronary artery disease: a metaanalysis of contemporary randomized controlled trials[J]. Int J Cardiol, 2021, 324: 1321.
[10] Bangalore S, Maron DJ, Stone GW, et al. Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and metaanalysis of randomized trials[J]. Circulation, 2020, 142(9): 841857.
[11] 卢淑霞,刘燕平,夏荣梅.采用冠脉介入术治疗冠心病不稳定型心绞痛的疗效分析[J].系统医学,2023,8(21):113-115+119.
[12] 黄宏伟,岳莹.冠脉介入治疗高龄冠心病心绞痛患者的疗效及安全性研究[J].航空航天医学杂志,2023,34(10):1175-1177.
[13] 黎国德,闫文荷,韩克栋,许庆波.QFR在冠脉中度狭窄的稳定型心绞痛患者介入治疗中的研究[J].岭南急诊医学杂志,2023,28(05):462-464.
[14] 汪明,程彩云.冠脉介入术结合麝香保心丸对冠心病心绞痛患者的临床效果分析[J].心血管病防治知识,2023,13 (29): 18-21.
[15] 梁士民.冠脉介入治疗高龄冠心病心绞痛的临床效果及对并发症发生率的影响[J].智慧健康,2023,9(18):87-90+95.